Fah Deficiency
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin) (NCT03284658) | CENTOGENE GmbH Rostock | 2018-08-20 |
Track Fah Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.